Volume 10 Supplement 3
A multi-factor model for caspase degradome prediction
© Wee et al; licensee BioMed Central Ltd. 2009
Published: 3 December 2009
Caspases belong to a class of cysteine proteases which function as critical effectors in cellular processes such as apoptosis and inflammation by cleaving substrates immediately after unique tetrapeptide sites. With hundreds of reported substrates and many more expected to be discovered, the elucidation of the caspase degradome will be an important milestone in the study of these proteases in human health and disease. Several computational methods for predicting caspase cleavage sites have been developed recently for identifying potential substrates. However, as most of these methods are based primarily on the detection of the tetrapeptide cleavage sites - a factor necessary but not sufficient for predicting in vivo substrate cleavage - prediction outcomes will inevitably include many false positives.
In this paper, we show that structural factors such as the presence of disorder and solvent exposure in the vicinity of the cleavage site are important and can be used to enhance results from cleavage site prediction. We constructed a two-step model incorporating cleavage site prediction and these factors to predict caspase substrates. Sequences are first predicted for cleavage sites using CASVM or GraBCas. Predicted cleavage sites are then scored, ranked and filtered against a cut-off based on their propensities for locating in disordered and solvent exposed regions. Using an independent dataset of caspase substrates, the model was shown to achieve greater positive predictive values compared to CASVM or GraBCas alone, and was able to reduce the false positives pool by up to 13% and 53% respectively while retaining all true positives. We applied our prediction model on the family of receptor tyrosine kinases (RTKs) and highlighted several members as potential caspase targets. The results suggest that RTKs may be generally regulated by caspase cleavage and in some cases, promote the induction of apoptotic cell death - a function distinct from their role as transducers of survival and growth signals.
As a step towards the prediction of in vivo caspase substrates, we have developed an accurate method incorporating cleavage site prediction and structural factors. The multi-factor model augments existing methods and complements experimental efforts to define the caspase degradome on the systems-wide basis.
It is increasingly being recognized that proteolytic processing, or the specific and limited cleavage of proteins by enzymes called proteases, represents an important mechanism for cellular control in all living organisms . Elucidating the protease degradome - the complete substrate repertoire of the protease in a cell, tissue or organism - at the systems level will unravel important clues on protease function across biological pathways and inter-connections with other protease systems. However, the experimental discovery and validation of bona fide protease substrates require time consuming and laborious efforts. As such, computational tools for the prediction of protease degradomes will complement these efforts.
In recent years, much work had been done on the prediction of the substrates of caspases - a unique class of cysteine proteases which function as critical effectors of apoptosis, inflammation and other important cellular processes [2–4]. Caspases recognizes highly specific tetrapeptide motifs (denoted as P4-P3-P2-P1) and cleave substrates after the requisite Asp residue at P1 . Substrates of caspases belong to a myriad of protein classes such as structural elements of the cytoplasm and the nucleus, components of the DNA repair machinery, protein kinases, GTPases and viral structural proteins [6, 7]. Hundreds of caspase substrates have been reported and many more are expected to be discovered. Most of the current approaches for caspase substrates prediction are primarily based on the detection of cleavage sites on proteins using information encoded within the tetrapeptide motifs (reviewed in ). While the identification of the specific cleavage site on the primary sequence of a protein is necessary for substrate prediction, it is intuitive that the final proteolytic cleavage of a protein in vivo is contingent on a multitude of other factors in addition to the presence of cleavage sites. Based on our analysis on a dataset of 176 experimentally verified caspase substrates (details are available in Additional File 1), we found that 80% of substrates contain at least one other identical caspase cleavage site sequence which is not reported as a true cleavage site in the literature. Identical cleavage site sequences in Tpr (DDED2117) , p28BAP31 (AAVD163) [10–12], golgin 160 (SEVD311) , Topo I (PEDD123) [14, 15] and heterogeneous nuclear ribonucleoparticle C1/C2 (GEDD305) , are located at two distinct positions on the respective protein but only one was reported to be cleaved. Indeed, it is suggested that conformation of the local structure of the cleavage site and not just the primary sequence alone is required for protease cleavage. Unstructured regions of substrates appear to be more susceptible to cleavage than regions of secondary structure (helices and β-sheets) . Also, the structures of a number of in vivo caspase substrates such as Bid [17, 18], ICAD [19, 20] and pro-caspase-7 [21, 22] suggest that caspase cleavage sites have a preference for location within disordered or unstructured extended loops, in line with observations on protease substrates in general . It is also suggested that the location of cleavage sites is critical for substrate cleavage - a potential cleavage site needs to be located at the surface of the substrate, rather than within the hydrophobic core of the protein, in order to be accessible to the protease active site .
In this context, we are motivated to explore the integration of these structural factors with cleavage site prediction to better predict caspase substrates. We report that caspase cleavage sites have a higher propensity to locate in unstructured and solvent exposed regions on the substrate compared to non-cleavage sites. We propose a two-step, multi-factor model incorporating these factors together with the caspase cleavage sites prediction tools to augment the prediction of caspase substrates. When CASVM [25, 26] and GraBCas  were integrated into the model, prediction results were shown to achieve greater positive predictive values compared to CASVM or GraBCas alone. The model was able to reduce the false positive pool by up to 13% and 53% respectively while retaining all true positives. In addition, we applied our prediction model on the family of receptor tyrosine kinases (RTKs) and highlighted several members as potential caspase targets. The results suggest that RTKs may be generally regulated by caspase cleavage, and in some cases, promote the induction of apoptotic cell death - a function distinct from their role as transducers of survival and growth signals.
Structural tendencies of caspase cleavage sites
Multi-factor model for prediction of caspase substrates
Positive predictive values (PPV) of model prediction at various P-score cut-offs.
Prediction of caspase cleavage of RTKs
Receptor tyrosine kinases (RTKs) belong to a sub-class of the protein kinase superfamily which function as plasma membrane-bound receptors transducing extracellular signals mediating cell survival, proliferation, embryonic development, adult homeostasis and many other critical processes . As RTK activity in resting, normal cells is tightly controlled, mutations or structural aberrations in RTKs were shown to convert them to potent oncoproteins, contributing to the development and progression of many cancers. Interestingly, recent studies have implicated several members of the receptor tyrosine kinase (RTK) family - as such EGFR [29, 30], Erbb2 [31–33], MET [34–36], RET  and ALK  - as proteolytic targets of caspases during apoptosis. Given the pervasive role of RTKs in cell survival and proliferation pathways and their implications in diseases such as cancer, it is tempting to speculate if RTKs may be generally regulated by caspase activity and if many other RTKs remain hitherto undiscovered downstream targets of caspases. Accordingly, we applied the multi-factor model to predict for potential caspase substrates among the members of the RTK family and analyzed the results.
The complete repertoire of RTK sequences - 52 members across 16 sub-families, as listed in the KEGG database  - was retrieved from Uniprot database  and predicted for potential caspase substrates using the multi-factor model. Protein sequences of RTKs were submitted to the CASVM server under default settings and predicted cleavage sites were scored for their propensities for solvent exposure and unstructured regions as described earlier. Predicted cleavage sites with equal or less than the P-score cut-off of 0.3 were highlighted (results are listed in Additional File 2; P-score of 0.3 was chosen as it represented the highest possible cut-off before true positives were filtered as shown in Figure 5A). The results showed that all RTKs were predicted to possess caspase cleavage sites which are distributed throughout the length of the extracellular and intracellular regions of the RTKs. About 92% of all RTKs (48/52) possess cleavage sites on the intracellular region while about 98% (51/52) contain extracellular cleavage sites. While predicted cleavage sites localize throughout the length of the receptors, notable trends in the distribution of predicted sites imply functional significance downstream of caspase cleavage. A sizeable number of RTKs (~21%) were predicted for caspase cleavage sites at the juxtamembrane region on the cytoplasmic side of the receptors (defined as the receptor segment between the transmembrane and kinase domains). Interestingly, it was reported that caspase cleavage of MET receptor at Asp1000 results in the inactivation of functional MET receptor by loss of its signalling cytoplasmic domain, with the concomitant appearance of membrane bound MET and soluble intracellular MET fragments. The membrane-bound MET fragment prevents downstream survival activity by trapping its cognate ligand, while the intracellular MET fragment becomes ligand-independent. It is conceivable that caspase cleavage at the juxtamembrane sites on RTKs may lead to the truncation of the full length receptor into a membrane bound portion and an intracellular fragment, similar to the observation of MET cleavage. In addition, studies on caspase-cleaved RTKs suggest that intracellular RTK fragments may have downstream functional implications. The release of MET fragment containing the active kinase domain following caspase cleavage was shown to be pro-apoptotic in cells. Pro-apoptotic intracellular fragments were similarly observed downstream of caspase-mediated RET and Erbb2 cleavage as well. Observations on high-throughput proteomic screening of caspase substrates in Dix et al.  reported that a substantial number of caspase substrates are cleaved into persistently stable, domain-containing fragments, and further speculated that caspase-mediated proteolysis yields a class of effector protein fragments with novel functions. Also, caspase cleavage of ALK was found to unravel a pro-apoptotic intracellular region upstream of the cleavage site. Taken together, the presence of predicted juxtamembrane cleavage sites on the intracellular domain of the receptors indicate possible receptor cleavage which could lead to the interference of receptor signalling and the generation of pro-apoptotic signals.
On a related note, close to 80% (41/52) of all RTKs harbour caspase cleavage sites within the tyrosine kinase domain of the receptor. In particular, RTKs from the insulin receptor and FGF receptor sub-families are annotated with multiple cleavage sites within their tyrosine kinase domains. As these domains serve as key mediators of signal transduction for RTKs, structural alterations from caspase cleavage may lead to perturbations of downstream RTK signalling. Interestingly, studies by Tikhomirov et al.  indicate that proteolytic fragments bearing the motif "RLLGI" derived from the tyrosine kinase domains of EGFR, Erbb2, Erbb4, TrkA and VEGFR1 were able to induce apoptosis in cells. Indeed, caspase cleavage sites were predicted in the kinase domains of some of these receptors (EGFR; Asp770, Asp916, Erbb4; Asp878, Asp922 and VEGFR1; Asp958, Asp987 Asp1135), suggesting the possibility of caspase cleavage and release of pro-apoptotic intracellular kinase fragments. As the "RLLGI" motif is suggested to be prevalent among RTKs, it is possible that cleavage of the tyrosine kinase domains of several other RTKs could lead to the similar production of such pro-apoptotic fragments. Studies on Erbb2 cleavage have shown that caspase cleavage produced pro-apoptotic intracellular fragments downstream of the kinase domain in the C-terminal region of the receptor. Cleavage of EGFR at a comparable location was shown but no pro-apoptotic consequences were reported. Interestingly, the other members of the EGFR family, Erbb3 and Erbb4, were predicted to possess similarly located caspase cleavage sites, suggesting that these proteins could be caspase targets as well.
The presence and distribution of these predicted cleavage sites across the RTK family suggest a general role of caspase cleavage in regulating RTK function. It is tempting to speculate a phenomenon whereby caspase cleavage of RTKs leads to a molecular "life-death" switch which converts the pro-survival protein to a pro-apoptotic one through the exposure and/or the release of pro-apoptotic domains. The elegant integration of both anti- and pro-apoptotic functionalities on the same signalling protein is an uncommon but economical feature. As discussed in Fischer et al. , such dramatic reversal of protein function was similarly observed in the caspase cleavage of serine/threonine protein kinases, MEKK1 and MEKK4, which generated pro-apoptotic fragments upon cleavage at their kinase domains. Several other anti-apoptotic proteins such as Bcl-2 and Bcl-xl have been shown to be converted into pro-apoptotic molecules by caspase cleavage.
Intriguingly, most RTKs were predicted to harbour caspase cleavage sites on their extracellular domain. It is tempting to question if there are hitherto uncharacterized functional consequences of cleavage at these locations since all known substrate cleavage were reported to be localized only in the intracellular environment. Notably, active caspases were found to be released into the extracellular environment during apoptosis . In addition, work by Cowan and co-workers  provided evidence for the localization of active caspase-2, caspase-3 and caspase-7 to the membrane surfaces of apoptotic smooth muscle cells. Clearly, future investigations on caspase activity in the extracellular environment will shed light on the possibility of extracellular RTK cleavage and its downstream consequences. More importantly, the predicted cleavage sites on RTKs will generate useful hypotheses and experimental leads for the validation and characterization of caspase-mediated RTK regulation.
In this paper, we propose a multi-factor model for the prediction of caspase substrates using a two-step approach. The entire protein sequence is first scanned for potential cleavage sites using a caspase cleavage sites prediction algorithm. The predicted cleavage sites will be filtered using a scoring system (given as the P-score) which is based on the propensities of predicted cleavage sites to locate in unstructured (Cp) and solvent exposed regions (Sp) on the protein. Expert domain knowledge or user requirements will direct the appropriate selection of the P-score cut-off levels. We have adopted the use of secondary structure and solvent accessibilities prediction tools as there are very limited experimentally verified structures on caspase substrates. As the model is dependent on the accuracy of existing secondary structure and solvent accessibility prediction tools, advancements in these domains will be helpful for this purpose.
Recently, the incorporation of additional factors, such as secondary structures and solvent accessibilities, was found to increase accuracy in HIV protease substrates prediction . In that case, a three-level hierarchical classifier scans a protein sequence for HIV protease cleavage sites using specificity data and filters the output for sequences located within disorganized secondary structures and solvent exposed regions. These structural factors were similarly integrated with the neural network algorithms for RNA and DNA binding sites prediction and were found to be helpful [46, 47]. In our proposed method, instead of combining the prediction of cleavage sites specificity, secondary structures and solvent accessibilities into a single predictor, these factors were accounted in two distinct steps to address a couple of caveats implicit in protease substrate prediction. While cleavage sites were shown to preferentially locate in unstructured and solvent exposed regions, not all predicted cleavage sites with substantial propensity for these factors will be cleaved in vivo. It is conceivable that regulatory processes such as post-translational modifications and other protein-protein interactions will likely to influence the final proteolytic event. Conversely, predicted cleavage sites which are hidden in deep hydrophobic cores of proteins - hence characterized by low propensities for solvent exposure - cannot be ruled out as it is possible that these sequences may be exposed following an upstream proteolytic cleavage of the protein by the same or another protease. Evidently, the caspase-mediated cleavage of ETK (epithelial and endothelial tyrosine kinase) was suggested to proceed in a two-step fashion where the first caspase cleavage site of the protein exposes an internal cleavage site for a subsequent round of cleavage . The retinoblastoma protein, RB, the hepatocyte growth factor receptor, MET and GTP exchange factor for small G-protein Ras, RasGAP were all shown to be cleaved sequentially at multiple sites - further suggesting the possibility of structural changes following an upstream proteolytic cleavage event (reviewed in ). To circumvent these constraints, the proposed two-step model predicts for a broad pool of potential cleavage sites in the first step and filters the results through the P-score cut-off which can be appropriately assigned with expert domain knowledge or under different user requirements.
The two-step model was tested using two caspase cleavage site prediction methods - CASVM and GraBCas. It was shown that in both cases, the discrimination of predicted cleavage sites based on additional structural characteristics was helpful for reducing the false positives. The GraBCas-based model was shown to outperform the CASVM-based model by eliminating a greater percentage of false positives with full retention of true positives. A likely reason for the disparity in the results could be due to the different sequence windows used for prediction in each case. GraBCas requires only the tetrapeptide cleavage sequence, while a 24-mer peptide sequence (tetrapeptide sequence with flanking ten residues upstream and downstream) is needed for input into CASVM. Presumably, in the latter case, information encoded within factors for caspase cleavage site recognition would have overlapped to a greater extent or are more correlated with that for secondary structures and solvent exposure due to the longer sequence window. In any case, the results suggest that other cleavage sites prediction tools utilizing algorithms with low correlation with secondary structure and solvent accessibility prediction could be integrated into the model. Conversely, the addition of other factors with low correlations with cleavage site recognition would be helpful for improving prediction of substrate cleavage. Recent studies have suggested that exosites - or interaction sites distal from the enzyme active site - could mediate substrate cleavage and are responsible for non-canonical caspase substrate cleavage. Structural studies by Agniswarmy et al.  highlighted a symmetrical pentapeptide binding pocket on caspase-7 situated way from the active site which could function as an exosite. Exosites were also shown to be involved in proteolytic events mediated by blood coagulation proteases . Similarly, it was reported that post-translational events such as serine phosphorylation of caspase cleavage sites, particularly on the P4 and P1' residues [51, 52], and sumolyation  were inhibitory to substrate cleavage. It is likely that models incorporating these factors with existing caspase cleavage site prediction tools will enhance in vivo substrate prediction. As the prediction of other protease substrates is likely to be largely influenced by the set of factors similar to the ones suggested here, our proposed multi-factor model may be applicable to the prediction of other protease substrates given the required data.
In this paper, we analyzed the structural characteristics of reported caspase substrates and found that caspase cleavage sites are more likely to locate in unstructured and solvent exposed regions compared to non-cleavage sites. We hypothesized that the integration of these factors with cleavage sites prediction will improve substrate prediction by filtering out predicted cleavage site sequences with unfavourable structural characteristics. Consequently, we constructed a two-step model integrating these factors with existing cleavage sites prediction tools. Using an independent dataset of caspase substrates, the model incorporating CASVM or GraBCas was shown to achieve greater positive predictive values compared to these methods alone, and was able to reduce the false positives pool by up to 13% and 53% respectively while retaining all true positives. As the prediction of other protease substrates is likely to be largely influenced by the set of factors similar to the ones suggested here, the multi-factor prediction model may be applicable to the prediction of other protease substrates.
Future progress in computational prediction of caspase substrates, and possibly for other protease-substrate system, will clearly hinge on the careful selection and integration of factors for substrate cleavage. It is certain that such efforts will be greatly assisted as more data, such as resolved structures of caspase substrates, becomes available. As high through-put screening efforts by Mahrus et al.  and Dix et al.  have uncovered several hundred more caspase substrates over the past year - an apparent indication of the burgeoning potential for future discovery of novel substrates - it is expected that in silico work will continue to complement experimental studies in the challenging journey of defining the caspase degradome on the systems-wide basis.
Materials and methods
74 unique, experimentally verified cleavage sites were obtained from the dataset of caspase cleavage sites derived from Fischer et al.  (available in Additional File 3). 24-residue long subsequences comprising of the tetrapeptide sequence with flanking upstream 10 residues and downstream 10 residues (P14....P4P3P2P1......P10') were extracted from the respective substrates and assigned as "cleavage site" subsequences. One other tetrapeptide (not a verified cleavage site) was randomly selected on the respective substrate of each verified cleavage site and subsequences similar in length to the "cleavage site" subsequences were constructed. A total of 74 additional subsequences were constructed and designated as the "non-cleavage site" subsequences. Together, the pool of subsequences (148 in total) constitutes the analysis dataset and was used for the analysis of structural features and for the optimization of the prediction model parameters.
Quantitative measures of secondary structures and solvent accessibilities
Hn, En, Cn and Sn are the SABLE predicted output for helix, β-strand, coil and real-value score (ranging 0 to 6; 0 for fully buried and 6 for maximum exposure) for solvent accessibility for each residue at position n in the sequence of length N (1, 2, 3.... N). Smax is a constant with value of 144, which is the sum of real-value scores from SABLE II for all residues in the 24-mer subsequence assuming that each residue is maximally exposed to solvent (24 × 6 = 144).
The P-score is the weighted sum of Cp and Sp values where the weights are given by the coefficients α and β respectively. Using the analysis dataset, values of α and β were optimized to 0.3 and 0.7 respectively. Optimal α and β coefficient values were obtained by stepping through various combinations of values (0.0, 0.1, 0.2....1.0), and measuring the fraction of cleavage site subsequences and non-cleavage site subsequences retained at increasing P-score cut-offs (details are available in the Additional File 4).
Multi-factor model testing
For model testing, a test dataset of unique caspase cleavage sites (14 caspase substrates containing 17 unique cleavage site sequences; available in Additional File 3) was used. The test dataset was predicted for caspase cleavage sites using CASVM (P14P10' scanning window and P1 residue (Asp) options were selected) or GraBCas (cleavage sites were scored using the GraBCas matrices and the highest score was selected; cut-off of 0.1 was used). Predicted caspase cleavage sites were extracted from substrate sequences and 24-mer subsequences comprising of the predicted tetrapeptide sequences with flanking upstream ten residues and downstream ten residues (P14....P4P3P2P1......P10') were constructed and calculated for Sp, Cp and P-score values. Subsequences containing the cleavage sites were assigned as "true positives" while those containing non-cleavage sites were denoted as "false positives". Percentage of subsequences from both pools retained at each P-score cut-off (0.00, 0.05, 0.10...1.00) and corresponding positive predictive values (PPV) were calculated for both models. In this context, PPV measures the probability of hitting a true cleavage site when restricted to all predicted cleavage sites and is computed as TP/(TP+FP), where TP and FP are the number of "true positives" and "false positives" respectively.
Other papers from the meeting have been published as part of BMC Bioinformatics Volume 10 Supplement 15, 2009: Eighth International Conference on Bioinformatics (InCoB2009): Bioinformatics, available online at http://www.biomedcentral.com/1471-2105/10?issue=S15.
LJKW gratefully acknowledges the award of a research scholarship from the National University of Singapore.
This article has been published as part of BMC Genomics Volume 10 Supplement 3, 2009: Eighth International Conference on Bioinformatics (InCoB2009): Computational Biology. The full contents of the supplement are available online at http://www.biomedcentral.com/1471-2164/10?issue=S3.
- López-Otín C, Overall CM: Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol. 2002, 3: 509-519. 10.1038/nrm858.View ArticlePubMedGoogle Scholar
- Los M, Stroh C, Janicke RU, Engels IH, Schulze-Osthoff K: Caspases: more than just killers?. Trends Immunol. 2001, 22: 31-34. 10.1016/S1471-4906(00)01814-7.View ArticlePubMedGoogle Scholar
- Algeciras-Schimnich A, Bamhart BC, Peter ME: Apoptosis-independent functions of killer caspases. Curr Opin Cell Biol. 2002, 14: 721-726. 10.1016/S0955-0674(02)00384-8.View ArticlePubMedGoogle Scholar
- Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C: Vital functions for lethal caspases. Oncogene. 2005, 24: 5137-5148. 10.1038/sj.onc.1208524.View ArticlePubMedGoogle Scholar
- Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW: A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997, 272: 17907-11. 10.1074/jbc.272.29.17907.View ArticlePubMedGoogle Scholar
- Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 1999, 68: 383-424. 10.1146/annurev.biochem.68.1.383.View ArticlePubMedGoogle Scholar
- Fischer U, Janicke RU, Schulze-Osthoff K: Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003, 10: 76-100. 10.1038/sj.cdd.4401160.View ArticlePubMedGoogle Scholar
- Timmer JC, Salvesen GS: Caspase substrates. Cell Death Differ. 2007, 14: 66-72. 10.1038/sj.cdd.4402059.View ArticlePubMedGoogle Scholar
- Ferrando-May E, Cordes V, Biller-Ckovric I, Mirkovic J, Gorlich D, Nicotera P: Caspases mediate nucleoporin cleavage, but not early redistribution of nuclear transport factors and modulation of nuclear permeability in apoptosis. Cell Death Differ. 2001, 8: 495-505. 10.1038/sj.cdd.4400837.View ArticlePubMedGoogle Scholar
- Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA, Shore GC: p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol. 1997, 139: 327-338. 10.1083/jcb.139.2.327.PubMed CentralView ArticlePubMedGoogle Scholar
- Granville DJ, Carthy CM, Jiang H, Shore GC, McManus BM, Hunt DW: Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett. 1998, 437: 5-10. 10.1016/S0014-5793(98)01193-4.View ArticlePubMedGoogle Scholar
- Maatta J, Hallikas O, Welti S, Hilden P, Schroder J, Kuismanen E: Limited caspase cleavage of human BAP31. FEBS Lett. 2000, 484: 202-206. 10.1016/S0014-5793(00)02159-1.View ArticlePubMedGoogle Scholar
- Mancini M, Machamer CE, Roy S, Nicholson DW, Thomberry NA, Casciola-Rosen LA, Rosen A: Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol. 2000, 149: 603-612. 10.1083/jcb.149.3.603.PubMed CentralView ArticlePubMedGoogle Scholar
- Casiano CA, Ochs RL, Tan EM: Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ. 1998, 5: 183-190. 10.1038/sj.cdd.4400336.View ArticlePubMedGoogle Scholar
- Samejima K, Svingen PA, Basi GS, Kottke T, Mesner PW, Stewart L, Durrieu F, Poirier GG, Alnemri ES, Champoux JJ, Kaufmann SH, Earnshaw WC: Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis. J Biol Chem. 1999, 274: 4335-4340. 10.1074/jbc.274.7.4335.View ArticlePubMedGoogle Scholar
- Waterhouse N, Kumar S, Song Q, Strike P, Sparrow L, Dreyfuss G, Alnemri ES, Litwack G, Lavin M, Watters D: Heteronuclear ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of interleukin 1beta-converting enzyme-like proteases in apoptosis. J Biol Chem. 1996, 271: 29335-29341. 10.1074/jbc.271.46.29335.View ArticlePubMedGoogle Scholar
- Chou JJ, Li H, Salvesen GS, Yuan J, Wagner G: Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell. 1999, 96: 615-624. 10.1016/S0092-8674(00)80572-3.View ArticlePubMedGoogle Scholar
- McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D: Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell. 1999, 96: 625-634. 10.1016/S0092-8674(00)80573-5.View ArticlePubMedGoogle Scholar
- Otomo T, Sakahira H, Uegaki K, Nagata S, Yamazaki T: Structure of the heterodimeric complex between CAD domains of CAD and ICAD. Nat Struct Biol. 2000, 7: 658-662. 10.1038/77957.View ArticlePubMedGoogle Scholar
- Woo EJ, Kim YG, Kim MS, Han WD, Shin S, Robinson H, Park SY, Oh BH: Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol Cell. 2004, 14: 531-539. 10.1016/S1097-2765(04)00258-8.View ArticlePubMedGoogle Scholar
- Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y: Crystal structure of a procaspase-7 zymogen: Mechanisms of activation and substrate binding. Cell. 2001, 107: 399-407. 10.1016/S0092-8674(01)00544-X.View ArticlePubMedGoogle Scholar
- Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salvesen GS, Bode W: Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA. 2001, 98: 14790-14795. 10.1073/pnas.221580098.PubMed CentralView ArticlePubMedGoogle Scholar
- Hubbard SJ, Campbell SF, Thornton JM: Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J Mol Biol. 1991, 220: 507-530. 10.1016/0022-2836(91)90027-4.View ArticlePubMedGoogle Scholar
- Boyd SE, Pike RN, Rudy GB, Whisstock JC, Garcia de la Banda M: PoPS: a computational tool for modeling and predicting protease specificity. J Bioinform Comput Biol. 2005, 3: 551-85. 10.1142/S021972000500117X.View ArticlePubMedGoogle Scholar
- Wee LJ, Tan TW, Ranganathan S: SVM-based prediction of caspase substrate cleavage sites. BMC Bioinformatics. 2006, 7 (Suppl 5): S14-10.1186/1471-2105-7-S5-S14.PubMed CentralView ArticlePubMedGoogle Scholar
- Wee LJ, Tan TW, Ranganathan S: CASVM: web server for SVM-based prediction of caspase substrates cleavage sites. Bioinformatics. 2007, 23: 3241-3. 10.1093/bioinformatics/btm334.View ArticlePubMedGoogle Scholar
- Backes C, Kuentzer J, Lenhof HP, Comtesse N, Meese E: GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences. Nucleic Acids Res. 2005, 33 (Web server issue): W208-W213. 10.1093/nar/gki433.PubMed CentralView ArticlePubMedGoogle Scholar
- Hubbard SR, Miller WT: Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol. 2007, 19: 117-123. 10.1016/j.ceb.2007.02.010.PubMed CentralView ArticlePubMedGoogle Scholar
- Bae SS, Choi JH, Oh YS, Perry DK, Ryu SH, Suh PG: Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Lett. 2001, 491: 16-20. 10.1016/S0014-5793(01)02167-6.View ArticlePubMedGoogle Scholar
- He YY, Huang JL, Chignell CF: Cleavage of epidermal growth factor receptor by caspase during apoptosis is independent of its internalization. Oncogene. 2006, 25: 1521-1531. 10.1038/sj.onc.1209184.View ArticlePubMedGoogle Scholar
- Tikhomirov O, Carpenter G: Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin. J Biol Chem. 2001, 276: 33675-33680. 10.1074/jbc.M101394200.View ArticlePubMedGoogle Scholar
- Tikhomirov O, Carpenter G: Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation. Cancer Res. 2003, 63: 39-43.PubMedGoogle Scholar
- Strohecker AM, Yehiely F, Chen F, Cryns VL: Caspase cleavage of HER-2 releases a Bad-like cell death effector. J Biol Chem. 2008, 283: 18269-18282. 10.1074/jbc.M802156200.PubMed CentralView ArticlePubMedGoogle Scholar
- Tulasne D, Deheuninck J, Lourenco FC, Lamballe F, Ji Z, Leroy C, Puchois E, Moumen A, Maina F, Mehlen P, Fafeur V: Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol Cell Biol. 2004, 24: 10328-39. 10.1128/MCB.24.23.10328-10339.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Foveau B, Leroy C, Ancot F, Deheuninck J, Ji Z, Fafeur V, Tulasne D: Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor. Cell Death Differ. 2007, 14: 752-64. 10.1038/sj.cdd.4402080.View ArticlePubMedGoogle Scholar
- Deheuninck J, Foveau B, Goormachtigh G, Leroy C, Ji Z, Tulasne D, Fafeur V: Caspase cleavage of the MET receptor generates an HGF interfering fragment. Biochem Biophys Res Commun. 2008, 367: 573-577. 10.1016/j.bbrc.2007.12.177.View ArticlePubMedGoogle Scholar
- Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, Bredesen DE, Edery P, Mehlen P: The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 2000, 19: 4056-63. 10.1093/emboj/19.15.4056.PubMed CentralView ArticlePubMedGoogle Scholar
- Mourali J, Bénard A, Lourenço FC, Monnet C, Greenland C, Moog-Lutz C, Racaud-Sultan C, Gonzalez-Dunia D, Vigny M, Mehlen P, Delsol G, Allouche M: Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol. 2006, 26: 6209-22. 10.1128/MCB.01515-05.PubMed CentralView ArticlePubMedGoogle Scholar
- Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093/nar/28.1.27.PubMed CentralView ArticlePubMedGoogle Scholar
- The UniProt Consortium: The Universal Protein Resource (Uniprot). Nucleic Acids Res. 2008, 36: D190-D195. 10.1093/nar/gkn141.PubMed CentralView ArticleGoogle Scholar
- Dix MM, Simon GM, Cravatt BF: Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell. 2008, 134: 679-691. 10.1016/j.cell.2008.06.038.PubMed CentralView ArticlePubMedGoogle Scholar
- Tikhomirov O, Dikov M, Carpenter G: Identification of proteolytic fragments from ErbB-2 that induce apoptosis. Oncogene. 2005, 24: 3906-13. 10.1038/sj.onc.1208534.View ArticlePubMedGoogle Scholar
- Hentze H, Schwoebel F, Lund S, Keel M, Ertel W, Wendel A, Jäättelä M, Leist M: In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem Biophys Res Commun. 2001, 283: 1111-1117. 10.1006/bbrc.2001.4918.View ArticlePubMedGoogle Scholar
- Cowan KN, Leung WC, Mar C, Bhattacharjee R, Zhu Y, Rabinovitch M: Caspases from apoptotic myocytes degrade extracellular matrix: a novel remodeling paradigm. FASEB J. 2005, 19: 1848-1850.PubMedGoogle Scholar
- You L: Detection of cleavage sites for HIV-1 protease in native proteins. Comput Syst Bioinformatics Conf. 2006, 249-56. full_text.View ArticleGoogle Scholar
- Ahmad S, Gromiha MM, Sarai A: Analysis and prediction of DNA-binding proteins and their binding residues based on composition, sequence and structural information. Bioinformatics. 2004, 20: 477-486. 10.1093/bioinformatics/btg432.View ArticlePubMedGoogle Scholar
- Jeong E, Chung IF, Miyano S: A neural network method for identification of RNA-interacting residues in protein. Genome Inform. 2004, 15: 105-116.PubMedGoogle Scholar
- Wu YM, Huang CL, Kung HJ, Huang CY: Proteolytic activation of ETK/Bmx tyrosine kinase by caspases. J Biol Chem. 2001, 276: 17672-17678. 10.1074/jbc.M010964200.View ArticlePubMedGoogle Scholar
- Agniswamy J, Fang B, Weber IT: Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis. FEBS J. 2007, 274: 4752-4765. 10.1111/j.1742-4658.2007.05994.x.View ArticlePubMedGoogle Scholar
- Bode W, Brandstetter H, Mather T, Stubbs MT: Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C. Thromb Haemost. 1997, 78: 501-511.PubMedGoogle Scholar
- Tözsér J, Bagossi P, Zahuczky G, Specht SI, Majerova E, Copeland TD: Effect of caspase cleavage-site phosphorylation on proteolysis. Biochem J. 2003, 372: 137-43. 10.1042/BJ20021901.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang YP, Biernat J, Pickhardt M, Mandelkow E, Mandelkow EM: Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A. 2007, 104: 10252-10257. 10.1073/pnas.0703676104.PubMed CentralView ArticlePubMedGoogle Scholar
- Tan JA, Sun Y, Song J, Chen Y, Krontiris TG, Durrin LK: SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. J Biol Chem. 2008, 283: 18124-18134. 10.1074/jbc.M800512200.PubMed CentralView ArticlePubMedGoogle Scholar
- Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA: Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell. 2008, 134: 866-876. 10.1016/j.cell.2008.08.012.PubMed CentralView ArticlePubMedGoogle Scholar
- Wagner M, Adamczak R, Porollo A, Meller J: Linear regression models for solvent accessibility prediction in proteins. J Comput Biol. 2005, 3: 355-69. 10.1089/cmb.2005.12.355.View ArticleGoogle Scholar
- Adamczak R, Porollo A, Meller J: Accurate prediction of solvent accessibility using neural networks-based regression. Proteins. 2004, 56: 753-767. 10.1002/prot.20176.View ArticlePubMedGoogle Scholar
- Adamczak R, Porollo A, Meller J: Combining Prediction of Secondary Structure and Solvent Accessibility in Proteins. Proteins. 2005, 59: 467-475. 10.1002/prot.20441.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.